Intra-articular delivery of full-length antibodies through the use of an in situ forming depot
December 12, 2021
Previous PostLong-acting injectable formulation technologies: Challenges and opportunities for the delivery of fragile molecules
Next PostEvaluation of Loco-Regional Skin Toxicity Induced by an In Situ Forming Depot after a Single Subcutaneous Injection at Different Volumes and Flow Rates in Göttingen Minipigs
